PMS2 and Leigh syndrome: This risk varies by gene, in fact, the carriers of pathogenic variants in MLH1 and MSH2 genes have a higher cancer risk and a younger age at diagnosis compared with LS patients with pathogenic variants in MSH6 and PMS2 genes [3,20,23].